NO169490C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater

Info

Publication number
NO169490C
NO169490C NO891206A NO891206A NO169490C NO 169490 C NO169490 C NO 169490C NO 891206 A NO891206 A NO 891206A NO 891206 A NO891206 A NO 891206A NO 169490 C NO169490 C NO 169490C
Authority
NO
Norway
Prior art keywords
group
preparation
therapeutic active
analogy procedure
pyrrolopyrimidine derivatives
Prior art date
Application number
NO891206A
Other languages
English (en)
Norwegian (no)
Other versions
NO169490B (no
NO891206L (no
NO891206D0 (no
Inventor
Hiroshi Akimoto
Takenori Hitsaka
Tetsuo Miwa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26412276&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO169490(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO891206D0 publication Critical patent/NO891206D0/no
Publication of NO891206L publication Critical patent/NO891206L/no
Priority to NO910661A priority Critical patent/NO178304C/no
Publication of NO169490B publication Critical patent/NO169490B/no
Publication of NO169490C publication Critical patent/NO169490C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO891206A 1988-03-24 1989-03-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater NO169490C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO910661A NO178304C (no) 1988-03-24 1991-02-19 Mellomprodukt for fremstilling av pyrrolopyrimidinderivater

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7114988 1988-03-24
JP24537988 1988-09-29

Publications (4)

Publication Number Publication Date
NO891206D0 NO891206D0 (no) 1989-03-20
NO891206L NO891206L (no) 1989-09-25
NO169490B NO169490B (no) 1992-03-23
NO169490C true NO169490C (no) 1992-07-01

Family

ID=26412276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891206A NO169490C (no) 1988-03-24 1989-03-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater

Country Status (12)

Country Link
US (4) US4997838A (de)
EP (1) EP0334636B1 (de)
KR (1) KR960015967B1 (de)
CN (1) CN1029970C (de)
AT (1) ATE144513T1 (de)
CA (1) CA1340794C (de)
DE (1) DE68927354T2 (de)
DK (1) DK173980B1 (de)
ES (1) ES2092994T3 (de)
GR (1) GR3021733T3 (de)
HU (3) HU908458D0 (de)
NO (1) NO169490C (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
DK0460116T3 (da) * 1989-02-27 1998-03-30 Biocryst Pharm Inc 9-substitueret-8-usubstitueret-9-deazaguaniner
JP3015957B2 (ja) * 1989-05-29 2000-03-06 武田薬品工業株式会社 ピロロ[2,3―d]ピリミジン誘導体およびその製造法
JP2983254B2 (ja) * 1989-06-14 1999-11-29 武田薬品工業株式会社 ピロロ〔2,3―d〕ピリミジン誘導体の製造法およびその中間体
JPH03173890A (ja) * 1989-09-21 1991-07-29 Takeda Chem Ind Ltd ピロロ[2,3―d]ピリミジン誘導体,その製造法,用途及び中間体
EP0431953A3 (en) * 1989-12-08 1992-01-02 Takeda Chemical Industries, Ltd. Pyrrolopyrimidine derivatives, their production and use
US5248775A (en) * 1989-12-11 1993-09-28 The Trustees Of Princeton University Pyrrolo(2,3-d)pyrimidines
IL96531A (en) * 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
US5028608A (en) * 1989-12-11 1991-07-02 The Trustees Of Princeton University N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
KR0162654B1 (ko) * 1989-12-11 1998-11-16 알렌 제이. 시니스갤리 N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체
CA2032695A1 (en) * 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
CA2057635A1 (en) * 1990-12-14 1992-06-15 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
EP0530537B1 (de) * 1991-08-12 1997-01-08 Takeda Chemical Industries, Ltd. Kondensierte Pyrimidinderivate, ihre Herstellung und ihre Verwendung als Antitumormittel
DE69227561T2 (de) * 1991-08-21 1999-06-02 Eisai Co., Ltd., Tokio/Tokyo Kondensierte Pyrimidinderivate als Antitumorverbindungen
US5254687A (en) 1991-12-04 1993-10-19 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
US5196424A (en) * 1992-03-24 1993-03-23 Eli Lilly And Company N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids
US5235053A (en) 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
HUT70208A (en) * 1992-09-25 1995-09-28 Lilly Co Eli Process for preparing 5-substituted pyrrolo[2,3-d]-pyrimidines
US5278307A (en) * 1992-09-25 1994-01-11 Eli Lilly And Company Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates
US5426187A (en) * 1993-11-30 1995-06-20 Eli Lilly And Company Process for the preparation of 4-hydroxy-5-substituted ethynylpyrrolo [2,3-d]pyrimidine intermediates
MX9709867A (es) * 1995-06-07 1998-03-31 Pfizer Derivados de pirimidina condensados con un anillo heterociclico, composiciones que contienen los mismos, y uso de los mismos.
US6395733B1 (en) 1995-06-07 2002-05-28 Pfizer Inc Heterocyclic ring-fused pyrimidine derivatives
AU1794697A (en) * 1996-03-06 1997-09-22 Novartis Ag 7-alkyl-pyrrolo{2,3-d}pyrimidines
JP2000516961A (ja) * 1996-08-30 2000-12-19 イーライ・リリー・アンド・カンパニー 非古典的ピロロ[2,3―d]ピリミジン抗葉酸物質
HUP0003954A3 (en) * 1997-09-26 2002-12-28 Lilly Co Eli Processes and intermediates useful to prepare pyrrolo [2,3-d] pyrimidine derivatives
US6162914A (en) * 1998-04-24 2000-12-19 Cerbios-Pharma S.A. Process for the reduction of pterins
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
US6066732A (en) * 1998-08-21 2000-05-23 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
NZ515598A (en) * 1999-05-24 2004-05-28 Sankyo Co Synergistic medicinal compositions containing anti-Fas antibody and a compound having a folate antagonistic activity or a dihydrofolate reductase inhibiting activity
EP2289549A3 (de) 1999-10-01 2011-06-15 Immunogen, Inc. Immunokonjugate für Krebsbehandlung
US6229413B1 (en) 1999-10-19 2001-05-08 General Electric Company Support of stationary conductors for a circuit breaker
PT1382339E (pt) 1999-12-10 2008-02-06 Pfizer Prod Inc Composições que contêm derivados de pirrolo[2,3-d]- pirimidina
MXPA02008242A (es) * 2000-02-25 2002-11-29 Lilly Co Eli Nueva forma cristalina del acido n-[4- [2-(2-amino -4, 7- dihidro -4 -oxo-3h- pirrolo [2, 3-d]pirimidin -5-il) eitl]benzoil] -l-glutamico y procedimiento para su obtencion.
US6380829B1 (en) 2000-11-21 2002-04-30 General Electric Company Motor operator interlock and method for circuit breakers
JPWO2003002661A1 (ja) * 2001-06-28 2004-10-21 東レ株式会社 耐候性に優れたエポキシ樹脂組成物および繊維強化複合材料
KR20050086784A (ko) 2002-11-26 2005-08-30 화이자 프로덕츠 인크. 이식 거부반응의 치료 방법
CN100379729C (zh) * 2006-04-06 2008-04-09 海南天源康泽医药科技有限公司 硝基化合物及其在培美曲塞制备中的应用
CA2674698A1 (en) * 2007-01-19 2008-07-24 Chelsea Therapeutics, Inc. New classical antifolates
MX2009010568A (es) * 2007-04-03 2009-10-22 Reddys Lab Ltd Dr Formas solidas de pemetrexed.
US20090253720A1 (en) * 2008-04-07 2009-10-08 Chelsea Therapeutics, Inc. Antifolate compositions
HRP20140395T1 (hr) 2008-08-20 2014-06-06 Zoetis Llc SPOJEVI PIROLO[2,3-d]PIRIMIDINA
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
AU2010270596A1 (en) * 2009-07-08 2012-02-02 Chelsea Therapeutics, Inc. Stable crystalline polymorphs of the dipotassium salt of (S) -2- {4- [2- (2, 4-diamino-quinazolin-6-yl) -ethyl] -benzoylamino} -4-methylene-pentanedioic acid
KR20120103604A (ko) * 2009-11-06 2012-09-19 첼시 쎄라퓨틱스, 인코포레이티드 효소 저해성 화합물
WO2012064377A1 (en) * 2010-03-29 2012-05-18 Chelsea Therapeutics, Inc. Antifolate compositions
US20130183268A1 (en) 2010-07-19 2013-07-18 Bayer Healthcare Llc Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
WO2012017443A1 (en) 2010-08-02 2012-02-09 Neon Laboratories Ltd. Process for preparation of highly pure dialkyl pemetrexed
WO2012056285A1 (en) 2010-10-25 2012-05-03 Fresenius Kabi Oncology Ltd. An improved process for the preparation of pemetrexed
WO2012078708A1 (en) 2010-12-07 2012-06-14 Chelsea Therapeutics, Inc. Combination comprising methotrexate and an antifolate compound
US9051322B2 (en) * 2011-03-23 2015-06-09 Scinopharm Taiwan, Ltd. Process for the production of a pemetrexed salt
CN103030640B (zh) * 2012-06-11 2015-04-22 江苏豪森医药集团连云港宏创医药有限公司 一种培美曲塞或其盐的制备方法
US10793573B2 (en) * 2017-08-31 2020-10-06 Duquesne University Of The Holy Spirit First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532241A (en) * 1982-08-26 1985-07-30 Sri International 8,10-Dideazaminopterins
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater

Also Published As

Publication number Publication date
HU203105B (en) 1991-05-28
ES2092994T3 (es) 1996-12-16
HU215928B (hu) 1999-03-29
EP0334636A2 (de) 1989-09-27
DK173980B1 (da) 2002-03-25
HUT55396A (en) 1991-05-28
NO169490B (no) 1992-03-23
NO891206L (no) 1989-09-25
KR960015967B1 (ko) 1996-11-25
NO891206D0 (no) 1989-03-20
US5296600A (en) 1994-03-22
KR890014543A (ko) 1989-10-24
ATE144513T1 (de) 1996-11-15
HUT51624A (en) 1990-05-28
CN1037513A (zh) 1989-11-29
DK143789A (da) 1989-09-25
DE68927354T2 (de) 1997-03-20
HU908458D0 (en) 1991-07-29
US5539113A (en) 1996-07-23
DE68927354D1 (de) 1996-11-28
EP0334636B1 (de) 1996-10-23
DK143789D0 (da) 1989-03-22
US5106974A (en) 1992-04-21
US4997838A (en) 1991-03-05
CN1029970C (zh) 1995-10-11
EP0334636A3 (de) 1991-05-02
GR3021733T3 (en) 1997-02-28
CA1340794C (en) 1999-10-19

Similar Documents

Publication Publication Date Title
NO169490C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
PT83843B (pt) Processo para a preparacao de promedicamentos de rapamicina
DE69415445D1 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
DE69116135D1 (de) Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate
PT623133E (pt) Compostos de aminoalquilo substituidos
SE8603099D0 (sv) Distamycin derivatives and process for their preparation
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
ES2046641T3 (es) Composicion antitumoral.
ES2071667T3 (es) Derivados de anfotericina b.
TW336929B (en) Benzenesulphonamide derivatives, their preparation and their application in therapy
ES2096572T3 (es) Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion.
FR2642648B1 (fr) Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
IL103508A (en) Pyrazino £1, 2-a| pyrrolo £2, 1-c| £1, 4| benzodiazepine- 2-alkanoic acid derivatives having anti-allergic and anti-asthmatic activities, their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK1K Patent expired